Enhancing PD‐1 Blockade With CAR‐Macrophage Therapy in HER2+ Solid Tumors

MedComm – Oncology · Published 2025-09-01 · DOI 10.1002/mog2.70036

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1002/mog2.70036

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Colorectal Precancerous Lesions: Molecular Mechanisms, Research Tools, and Natural Product‐Based Clinical Translation · MedComm – Oncology · 2026 · Same journal
• Theranostic Advancements in Brain Cancer: Promising Approaches for Emerging Therapy · MedComm – Oncology · 2026 · Same journal
• The Role of Glycoprotein Non‐Metastatic Melanoma Protein B (GPNMB) in Tumors and Other Diseases · MedComm – Oncology · 2025 · Same journal
• SIRT7 Orchestrates Ligand‐Dependent ERα Signaling Rewiring to Drive Tamoxifen Resistance in ERα‐positive Breast Cancer · MedComm – Oncology · 2026 · Same journal
• A Causal Relationship Between Genetically Proxied Inhibition of HMGCR, NPC1L1, and PCSK9 and Cancers · MedComm – Oncology · 2025 · Same journal
• Tumor‐Resident Mast Cells Facilitated Breast Cancer Progression via Activating Type I Interferon Pathway · MedComm – Oncology · 2026 · Same journal
• Cancer Comorbidities: Clinical Impacts, Mechanistic Insights, and Management Strategies · MedComm – Oncology · 2026 · Same journal
• Targeting Tumor Dormancy and Recurrence: Molecular Mechanisms and Peptide Therapeutic Delivery · MedComm – Oncology · 2026 · Same journal
• The Dual Role of Autophagy in Cancer: Mechanisms and Therapeutic Strategies · MedComm – Oncology · 2026 · Same journal
• Zinc‐Coordination‐Driven Pyroptosis Nano‐Inductor Sensitizes Colorectal Cancer Chemo‐Immunotherapy by Specific Delivery and Cell Stemness Suppression · MedComm – Oncology · 2026 · Same journal